TREACE MEDICAL CONCEPTS, INC. (TMCI) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, TREACE MEDICAL CONCEPTS, INC.'s filing signal continuing negative.

Treace Medical Concepts, Inc. is a medical technology company focused on advancing the standard of care for surgical management of bunions and related midfoot deformities. The company pioneered the Lapiplasty(R) 3D Bunion Correction System, a proprietary combination of instruments, implants, and surgical methods designed to correct bunion deformities in three planes and stabilize the joint. Treace also offers the Adductoplasty(R) Midfoot Correction System, Nanoplasty(R) 3D Minimally Invasive Bunion Correction System, PercuplastyTM Percutaneous 3D Bunion Correction System, and the SpeedMTP(R) System for great toe fusions. The company markets and sells its products in the United States through a direct employee sales force supplemented by independent sales agencies, focusing on training physicians and educating patients.

Revenue is generated from the sale of bunion implant kit systems, single-use sterile instruments, and other complementary products. Sales are driven by the adoption and utilization of its Lapiplasty System and other bunion correction solutions by surgeons.